Creating Our Clean Energy Future: PG&E Customers Receive 93% of Their Electricity from Greenhouse Gas-Free Resources
Large-Scale Solar, Battery Energy Storage Helping to Build Climate-Resilient Grid SAN FRANCISCO–(BUSINESS WIRE)–Pacific Gas and…
Large-Scale Solar, Battery Energy Storage Helping to Build Climate-Resilient Grid SAN FRANCISCO–(BUSINESS WIRE)–Pacific Gas and…
DUBLIN–(BUSINESS WIRE)–The “2021 Focus Series: ESG – Social Considerations for Insurers” report from Conning &…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for January 2022. The indices track…
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
BEIJING–(BUSINESS WIRE)–HARMAY, the new retail beauty brand, has concluded its Series C and D rounds…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its inaugural solar loan index publication, providing monthly credit trends of…
The fastest organic growth auto retailer in U.S. history also ranks top 10 overall among…
WASHINGTON–(BUSINESS WIRE)–The American Association of Colleges of Nursing (AACN) is pleased to announce the results…
Insurity’s cloud-native, configurable underwriting solution enables Pennsylvania Lumbermens Mutual Insurance Company to automate core processes…
MISSISSAUGA, Ontario, Feb. 11, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Investigator-sponsored studies show UB-612 induces high antibody activity against multiple variants, including Alpha, Beta, Delta,…
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Amolyt Pharma, a global…
REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaper BriLife vaccine…
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage…
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a clinical-stage cell…
WOBURN, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
SCOTTSDALE, Ariz., Feb. 11, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”),…
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…